journal
https://read.qxmd.com/read/38619057/assessing-men-with-opioid-use-disorder-for-testosterone-deficiency-after-the-development-of-symptoms
#1
JOURNAL ARTICLE
Bhavna Bali, Wen Jan Tuan, Alyssa Scott, Pooja Bollampally, Destin Groff, Shou Ling Leong, Van L King, Curtis Bone
OBJECTIVE: Individuals with opioid use disorder (OUD) have reduced life expectancy and inferior outcomes when treated for depression, diabetes, and fractures. Their elevated risk of testosterone deficiency may contribute to all of these relationships, however few individuals prescribed opioids are evaluated with testosterone assays. The purpose of this study is to determine whether patients with opioid use disorder are evaluated for testosterone deficiency after development of a symptom that may merit investigation, such as erectile dysfunction (ED)...
April 15, 2024: Journal of Addictive Diseases
https://read.qxmd.com/read/38619008/perceptions-of-family-functioning-impact-smoking-during-pregnancy
#2
JOURNAL ARTICLE
Nancy C Jao, Marcia M Tan, Ariana Albanese, Jacinda Lee, Laura R Stroud
BACKGROUND: Although socio-environmental factors are known to contribute to the maintenance of smoking behavior, few studies have examined the impact of family functioning on smoking during pregnancy. OBJECTIVE: The current study examined the relationship between perceptions of family functioning and smoking during pregnancy. METHODS: Pregnant women ( N  = 345, 59% ethnic/racial minority) completed the Family Assessment Device, a gold-standard assessment examining perceptions of family functioning in seven domains...
April 15, 2024: Journal of Addictive Diseases
https://read.qxmd.com/read/38605500/quantifying-diagnosis-and-treatment-practices-of-opioid-use-disorder-in-primary-care-practices-using-chart-review-data
#3
JOURNAL ARTICLE
Elisabeth F Callen, Tarin Clay, Cory Lutgen, Elise Robertson, Elizabeth W Staton, Melissa K Filippi
BACKGROUND: Opioid misuse is a significant public health crisis. The aim sought to identify potential gaps in opioid care in primary care practices. METHODS: American Academy of Family Physicians (AAFP) offered a monthly online educational series to seven U.S. practices. Practices were asked to complete up to 50 chart reviews for visits during two periods: February-April, 2019, and February-April, 2022. Each chart had to have an ICD-10 diagnosis of opioid misuse, opioid dependence, or opioid use...
April 11, 2024: Journal of Addictive Diseases
https://read.qxmd.com/read/38594626/impulsivity-self-regulation-and-response-withholding-in-university-student-drinkers
#4
JOURNAL ARTICLE
Mansour Bagheri, W Miles Cox, James Intriligator, Leyla Mizani
This study was designed to determine how impulsivity, self-regulation, and response withholding are related to one another and to university students' drinking behavior. Participants ( N  = 108) completed measures of impulsivity, self-regulation, and alcohol consumption. In addition, a computerized Go/No Go task and a backward memory task were used to measure participants' behavioral impulsivity and their memory capacity. The aim was to determine whether (a) light/moderate and heavy drinkers would respond differently when the task stimuli were alcohol-related compared to when they were alcohol-unrelated and (b) whether the accuracy of participants' responses was related to their cognitive ability...
April 9, 2024: Journal of Addictive Diseases
https://read.qxmd.com/read/38591227/systematic-review-of-cognitive-and-behavioral-strategies-used-in-effective-harm-reduction-interventions-for-people-who-use-cocaine
#5
REVIEW
Carolina Pinzón-Gómez, Juan Pablo Langlade, Carlos Gantiva
OBJECTIVE: The aim of this systematic review is to identify cognitive and behavioral strategies that have been used in effective harm reduction interventions for people who use cocaine. METHOD: Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed, and the search was performed on February 26, 2023 across databases including PsycInfo, PubMed, Scopus, and Web of Science. Studies were included if they (1) report the use of one cognitive or behavioral strategy, (2) have harm reduction as the objective, (3) involve participants who used cocaine as at least one of their substances, (4) be published within the last 10 years, and (5) have a randomized controlled trial design...
April 9, 2024: Journal of Addictive Diseases
https://read.qxmd.com/read/38566305/illness-related-outcomes-of-illicit-substance-use-disorder-in-adolescents-with-early-onset-schizophrenia-a-multicenter-study
#6
JOURNAL ARTICLE
Serkan Turan, Çağatay Ermiş, Şafak Eray, Nilay Ağaç, Oğuz Bilal Karakuş, Yeşim Sağlam, Aylin Bandırma, Duru Güler, Mustafa Tunçtürk, Remzi Oğulcan Çıray, Gül Karaçetin, Neslihan İnal, Alp Üçok
OBJECTIVES: Lifetime co-occurring substance use disorders are common at the time of presentation for the treatment of primary psychosis. Our aim was to investigate the clinical characteristics of adolescents with early-onset schizophrenia/schizoaffective disorder (EOS), categorized as either with (EOS + SUD) or without SUD (non-SUD/EOS), in a multi-center sample. METHODS: Between 2016 and 2022, 255 patients were evaluated across three tertiary-care inpatient units...
April 2, 2024: Journal of Addictive Diseases
https://read.qxmd.com/read/38555861/blood-pressure-response-to-extended-release-naltrexone-in-heroin-and-prescription-opioid-users-and-its-implications-for-cardiovascular-morbidity
#7
JOURNAL ARTICLE
Zhenhao Shi, Daniel D Langleben, David Rott, Mark Albanese, Igor Elman
BACKGROUND: Consuming opioid agonists is a risk factor for cardiovascular disease particularly in intravenous heroin users. The monthly injectable extended-release opioid antagonist, naltrexone (XR-NTX) is an effective treatment for opioid use disorder. The impact of opioid receptor blockade through XR-NTX on blood pressure, a critical risk factor for cardiovascular morbidity, has not yet been characterized. METHODS: The study evaluated the change in blood pressure during XR-NTX treatment among 14 patients who predominately used intravenous heroin and 24 patients who used prescription oral opioids, all with opioid use disorder...
March 31, 2024: Journal of Addictive Diseases
https://read.qxmd.com/read/38504419/explaining-the-high-mortality-among-opioid-cocaine-co-users-compared-to-opioid-only-users-a-systematic-review
#8
REVIEW
Jan van Amsterdam, Wim van den Brink
RATIONALE: The opioid crisis in North America has recently seen a fourth wave, which is dominated by drug-related deaths due to the combined use of illicitly manufactured fentanyl [IMF] and stimulants such as cocaine and methamphetamine. OBJECTIVES: A systematic review addressing the question why drug users combine opioids and stimulants and why the combination results in such a high overdose mortality: from specific and dangerous pharmacokinetic or pharmacodynamic interactions or from accidental poisoning? RESULTS: Motives for the combined use include a more intensive high or rush when used at the same time, and some users have the unfounded and dangerous belief that co-use of stimulants will counteract opioid-induced respiratory depression...
March 19, 2024: Journal of Addictive Diseases
https://read.qxmd.com/read/38504415/exploring-sub-threshold-food-addiction-in-adult-patients-with-severe-obesity-a-cross-sectional-analysis
#9
JOURNAL ARTICLE
Aymery Constant, Mickaël Som, David Val-Laillet, Romain Moirand, Ronan Thibault
BACKGROUND: Most studies on Food Addiction (FA) used the strict classical diagnosis approach without quantifying sub-threshold symptoms (i.e. uncontrolled/excessive food intake, negative affect, craving, tolerance, withdrawal, and continued use despite harm) nor indicating where they stand on the "three-stage addiction cycle" modeling the transition from substance use to addiction. OBJECTIVES: (1) to estimate the proportion of clinically significant episodes of distress/impairment in severely obese patients without FA, and (2) to assess their associations with FA symptoms at the subthreshold level...
March 19, 2024: Journal of Addictive Diseases
https://read.qxmd.com/read/38468374/functional-connectivity-alterations-in-individuals-with-gaming-disorder-assessed-by-functional-magnetic-resonance-imaging-a-systematic-review
#10
REVIEW
Apolinario de Oliveira Botelho, Francieli Bernardo Ribeiro, Jéssica Soares Machado, Daiane Cristini Barbosa de Souza
Neuroimaging has continually advanced, playing a crucial role in the accurate diagnosis of various brain pathologies and disorders. This integrative review aimed to identify the main changes in brain connections found in fMRI scans of individuals with Internet Gaming Disorder (IGD). The data collection method involved searching for the terms "Magnetic Resonance Imaging", "Psychological Dependence" and "Internet Addiction Disorder" in the PubMed and Embase databases. Studies published between 2020 and January 2023 were included and manually analyzed through the virtual environment created in the "Rayyan" software, compiling a total of 18 scientific studies...
March 11, 2024: Journal of Addictive Diseases
https://read.qxmd.com/read/38439513/president-s-message
#11
JOURNAL ARTICLE
Jon Lepley
No abstract text is available yet for this article.
March 4, 2024: Journal of Addictive Diseases
https://read.qxmd.com/read/38400724/10-year-retention-of-a-comprehensive-treatment-model-of-buprenorphine-for-opioid-use-disorder
#12
JOURNAL ARTICLE
Wanhong Zheng, Megan Cavrak, Hannah Bowles, Yongjia Deng, Sijin Wen, Si Gao, Laura Lander, James Berry, Erin L Winstanley
BACKGROUND: There has been extensive research demonstrating the effectiveness of medications for opioid use disorder (MOUD) but limited investigation into its long-term retention rate. OBJECTIVE: Assess the long-term treatment retention of a buprenorphine-based MOUD clinic with additional stratifications by age and gender. METHODS: This retrospective study analyzed 10-years of data from a MOUD clinic in West Virginia that served 3,255 unique patients during the study period (2009-2019)...
February 24, 2024: Journal of Addictive Diseases
https://read.qxmd.com/read/38369773/trends-in-maternal-opioid-use-statewide-differences-by-sociodemographic-characteristics-in-florida-from-2000-to-2019
#13
JOURNAL ARTICLE
Amanda L Elmore, Nansi S Boghossian, Alexander C McLain, Suzanne McDermott, Jason L Salemi
BACKGROUND: Maternal opioid use (MOU) remains a public health concern. Studies have demonstrated significant increases in MOU, but estimates using ICD-10-CM or stratified by sociodemographic variables are limited. OBJECTIVES: Using a statewide, population-based dataset of Florida resident deliveries from 2000 to 2019, we examined the trend of MOU by age, race/ethnicity, education level, and insurance. METHODS: Florida administrative data was used to conduct a retrospective cohort study...
February 18, 2024: Journal of Addictive Diseases
https://read.qxmd.com/read/38369467/short-term-effects-of-semaglutide-among-patients-with-obesity-with-and-without-food-addiction-an-observational-study
#14
JOURNAL ARTICLE
Joana Nicolau, María Isabel Tamayo, Pilar Sanchís, Antelm Pujol, Guadalupe Pérez-Bec, Guido Sfondrini, Lluís Masmiquel
INTRODUCTION: Food addiction (FA) is highly prevalent among people with obesity (PwO) and may constitute a key factor in weight loss failure or weight regain. GLP-1 analogues have been shown to act on the mesolimbic system, which is related to hedonic overeating and substance abuse. We aimed to study the effects of low doses of semaglutide on FA symptomatology and to evaluate whether the presence of FA have a negative impact on weight loss despite treatment with semaglutide. METHODS: One hundred and thirteen PwO (45...
February 18, 2024: Journal of Addictive Diseases
https://read.qxmd.com/read/38355422/prevalence-and-drug-use-correlates-of-inadvertent-fentanyl-exposure-among-individuals-misusing-drugs-in-seven-u-s-states
#15
JOURNAL ARTICLE
S Magura, M J Lee-Easton, R Abu-Obaid, P Reed, B Allgaier, E Fish, A L Maletta, P Amaratunga, B Lorenz-Lemberg, M Levitas, E D Achtyes
Fentanyl has emerged as the leading cause of fatal drug overdoses in the U.S. Individuals misusing drugs may not always be aware of exposure to fentanyl. To determine the prevalence of fentanyl use and extent of awareness of fentanyl exposure among a national sample of treatment-seeking individuals with opioid use disorder ( n  = 1098). Participants provided oral fluid and urine specimens, which were tested for drugs by liquid chromatography/tandem mass spectrometry. Participants also provided self-reports of fentanyl use...
February 14, 2024: Journal of Addictive Diseases
https://read.qxmd.com/read/38269542/buprenorphine-two-adolescent-case-reports-of-bridging-the-transmucosal-form-to-the-extended-release-subcutaneous-injectable-form
#16
JOURNAL ARTICLE
Vivek Velagapudi, Luke Schuster, Roopa Sethi
According to the Centers for Disease Control and Prevention (CDC), 100,306 drug overdose deaths occurred in the US during a 12-month period ending in April 2021. Opioids were involved in 75% of these related deaths. Opioid Use Disorder (OUD) is a constantly evolving public health crisis with potentially lethal consequences. In 2017, 900 adolescents began to misuse opioids every day. Nearly 10% of high school seniors reported using opioids nonmedically. Additionally, the incidence for hospitalizations for adolescents among children 1-19 years of age increased nearly 2-fold from 1997 to 2012...
January 25, 2024: Journal of Addictive Diseases
https://read.qxmd.com/read/38115193/mandating-reimbursement-for-non-fda-regulated-cannabis-is-bad-public-policy
#17
JOURNAL ARTICLE
Stuart Gitlow, Gregory Bunt, Frank Dowling
An influential cannabis lobby and its allies are engaged in an aggressive initiative to mandate health and worker's compensation insurance coverage for non-standardized, non-FDA-regulated cannabis products. If successful, mandated reimbursement would present a severe public health risk and force taxpayers to fund a risky and under-regulated industry. Leaders in psychiatry and other medical specialties have sounded the alarm about the marketing and sale of cannabis products for medical uses without prior review by the FDA...
December 19, 2023: Journal of Addictive Diseases
https://read.qxmd.com/read/38112194/suicidal-ideations-and-self-dehumanization-in-recently-detoxified-patients-with-severe-alcohol-use-disorder-an-experimental-exploration-through-joint-explicit-implicit-measures
#18
JOURNAL ARTICLE
Sullivan Fontesse, Tina Chevallereau, Florence Stinglhamber, Stéphanie Demoulin, Anna Fiorito, Armand Chatard, Nemat Jaafari, Pierre Maurage
BACKGROUND: Metadehumanization (the feeling of being considered as less than human by others) is a pervasive phenomenon in psychiatric states, notably promoting self-dehumanization and suicide antecedents. However, its role in suicidal ideations among patients with addictive disorders remains unexplored. We thus investigated the involvement of metadehumanization/self-dehumanization in suicidal ideations and suicidal thoughts interference in severe alcohol use disorder. METHODS: We measured metadehumanization, suicidal ideations, and desire for social contact through questionnaires among 35 recently detoxified patients with severe alcohol use disorder (26 males)...
December 19, 2023: Journal of Addictive Diseases
https://read.qxmd.com/read/38105430/a-social-media-analysis-of-kratom-use-to-discontinue-stimulants
#19
JOURNAL ARTICLE
Jill R Settle, Alexandria Smith, Paula Rausch
BACKGROUND: While FDA-approved treatments exist for opioid use disorder, none are available for stimulant use disorder. Kratom (Mitragyna speciosa), an unregulated plant-derived substance with known opioid- and stimulant-like effects, has been used to self-treat opioid use disorder; however, its use in relation to stimulant use disorder has not been described. OBJECTIVE: To understand whether and how individuals use kratom to self-treat stimulant use disorder. METHODS: Using a commercially available social listening platform, 3,820 publicly available social media posts published between January 1, 2020, and June 21, 2021, were reviewed for relevance to kratom and stimulant discontinuation...
December 17, 2023: Journal of Addictive Diseases
https://read.qxmd.com/read/38095574/severe-tianeptine-withdrawal-symptoms-managed-with-medications-for-opioid-use-disorder-a-case-report
#20
JOURNAL ARTICLE
Varun Y Rawal, Matthew Gallardo, Katelyn Henderson, Orman Trent Hall, Nicholas Klisovic, Eleonora Sikic-Klisovic
INTRODUCTION: Tianeptine is a tricyclic antidepressant (TCA) without FDA-approval that acts on dopamine and norepinephrine. It has opioid agonist activity and is increasingly being used for recreational purposes to achieve an opioid-like anxiolytic effect. This can lead to clinical addiction with subsequent withdrawal symptoms resembling symptoms of opioid withdrawal. There are limited cases detailing the management of tianeptine withdrawal. CASE SUMMARY: We present the case of a 38-year-old male with chronic tianeptine use admitted to the Intensive Care Unit for treatment of encephalopathy and vital sign changes due to intake of multiple substances and suspected tianeptine withdrawal...
December 14, 2023: Journal of Addictive Diseases
journal
journal
30729
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.